AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02283502 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MRgHIFU system
Description: Magnetic resonance-guided high-intensity focused ultrasound (MRgHIFU) system for the noninvasive treatment of uterine fibroids
Study NCT01719692 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituximab
Study NCT01719692 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rituximab
Study NCT03929835 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cannabis oil
Description: T1/C20 CBD
Study NCT02684526 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Eovist Contrast
Description: Subjects will undergo an MRI (magnetic resonance imaging) scan using the Eovist contrast agent. This MRI scan takes approximately 45minutes to 1 hour to complete.
Study NCT02684526 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Non Eovist Contrast
Description: Subjects will undergo an MRI (magnetic resonance imaging) scan using a contrast agent other than Eovist. This MRI scan takes approximately 45minutes to 1 hour to complete.
Study NCT03929835 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Olive oil with chlorophyl
Study NCT01899469 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Electromagnetic Therapy
Description: 20 sessions from Monday to Friday of 20 minutes of Electromagnetic Therapy, using the next parameters: 10 Hz of frequency and 60% of intensity, and 20 sessions from Monday to Friday of 25 minutes of Back School, the exercises were based on the re-education of breathing, self stretching trunk muscles, erector spine reinforcement, abdominal reinforcement and postural exercises. The participants had been performing 8 to 10 repetitions of each exercise and they had been recommended about making a series more at home.
Study NCT01899469 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Neurological Stimulation
Description: Procedure/Surgery: Transcutaneous Electrical Neurological Stimulation (TENS)~20 sessions from Monday to Friday of 20 minutes of TENS Therapy using the next parameters: 100μs of impulse width, 80 Hz of impulse frequency, and 20 sessions from Monday to Friday of 25 minutes of Back School, the exercises were based on the re-education of breathing, self stretching trunk muscles, erector spine reinforcement, abdominal reinforcement and postural exercises. The participants had been performing 8 to 10 repetitions of each exercise and they had been recommended about making a series more at home.
Study NCT01899469 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Back School
Description: 25 minutes of Back School, the exercises were based on the re-education of breathing, self stretching trunk muscles, erector spine reinforcement, abdominal reinforcement and postural exercises. The participants had been performing 8 to 10 repetitions of each exercise and they had been recommended about making a series more at home.
Study NCT01994304 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: SCC
Description: The intervention involves introducing and orienting health providers on the SCC, facilitating availability of a specific set of commodities and regular targeted supervision. These are expected to improve adherence to life saving interventions immediately before, during and after birth, and reduce intrapartum mortality (still births and very early neonatal deaths).
Study NCT00554749 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Interventions at home, in the kindergarten/school
Description: Weekly interventions including behavior techniques (stimulus fading)
Study NCT02031445 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MRX-6
Study NCT02031445 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT02267746 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tazarotene (Fabior™)
Study NCT00943826 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: 10 mg/kg intravenously q2w in the Concurrent and Maintenance Phases. 15 mg/kg intravenously q3w in the Monotherapy Phase.
Study NCT00943826 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temozolomide
Description: 75 mg/m\^2 once daily for 6 weeks, followed by 150-200 mg/m\^2 once daily on days 1-5 of six 4 week cycles.
Study NCT00943826 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Temozolomide
Description: 75 mg/m\^2 once daily for 6 weeks, followed by 150-200 mg/m\^2 once daily on days 1-5 of six 4 week cycles.
Study NCT00943826 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation therapy
Description: 30 fractions of 2 Gy delivered on days 1-5 per week for 6 weeks.
Study NCT00943826 — intervention group
Intervention type: RADIATION
Group type: PLACEBO_COMPARATOR
Intervention: Radiation therapy
Description: 30 fractions of 2 Gy delivered on days 1-5 per week for 6 weeks.
Study NCT00943826 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Intravenously q2w in the Concurrent and Maintenance Phases and q3w in the Monotherapy Phase.
Study NCT02267746 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tazarotene (Actavis)
Study NCT02267746 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle foam
Study NCT00050167 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: 80 mg/m\^2 by vein (IV) Weekly Over 1 Hour x 12 Weeks
Study NCT05716711 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: LAVENDER OIL
Description: IT WILL BE APPLIED TO 60 PATIENTS, 20 IN EACH GROUP, WITH A COLOSTOMY
Study NCT00050167 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Docetaxel
Description: 75 mg/m\^2 by vein (IV) Over 1 Hour Once Every 3 Weeks
Study NCT00050167 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: 1500 mg/m\^2 by mouth Twice Daily x 2 Weeks
Study NCT00689481 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: U0267 Foam
Description: All treatments will be administered topically twice daily (morning and evening) for 8 weeks to areas affected with psoriasis (excluding face and scalp).
Study NCT00689481 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle foam
Description: All treatments will be administered topically twice daily (morning and evening) for 8 weeks to areas affected with psoriasis (excluding face and scalp).
Study NCT04099524 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: tDCS
Description: tDCS (LPG/C3-anode, orbitofrontal cortex/Fp2-cathode) will be administered for 4 weeks (1 session per weekday for 2 weeks, and then 2 sessions per week for 2 weeks, for a total of 14 sessions). All subjects will receive anodal tDCS stimulation for 20 minutes per session, on C3 and the cathode electrode on Fp2 using 10/20 EEG system. tDCS will be applied with a pair of 35 cm2 single-use sponges soaked in approximately 4mL of saline solution on each side (\~8mL per sponge) connected to the stimulator. During the 20-minute tDCS session, we will use online tDCS design (i.e., a subject will simultaneously work on the visual attention-oriented task.
Study NCT04099524 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: tDCS
Description: tDCS (LPG/C3-anode, orbitofrontal cortex/Fp2-cathode) will be administered for 4 weeks (1 session per weekday for 2 weeks, and then 2 sessions per week for 2 weeks, for a total of 14 sessions). All subjects will receive anodal tDCS stimulation for 20 minutes per session, on C3 and the cathode electrode on Fp2 using 10/20 EEG system. tDCS will be applied with a pair of 35 cm2 single-use sponges soaked in approximately 4mL of saline solution on each side (\~8mL per sponge) connected to the stimulator. During the 20-minute tDCS session, we will use online tDCS design (i.e., a subject will simultaneously work on the visual attention-oriented task.
Study NCT04230642 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: The Quantum Surgical device
Description: Robotic platform for needle placement
Study NCT04232163 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Arm Boot Camp
Description: The intervention involves a combination of daily homework based upper limb exercises and feedback from an activity monitor to motivate use of the affected upper limb. Participants will be supported through virtual sessions with a therapist.
Study NCT02130401 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TNM (thermoneuromodulation device)
Description: The device is worn like a music headset and the patient lies on a wedge pillow while the device is active. Each session lasts under 20 minutes.
Study NCT04284696 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Pregnan-C-Gum(R) chewing gum
Description: Using a chewing gum with 150mg vitamin C (per piece/gum) for 14 days ad libitum
Study NCT04284696 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo chewing gum
Description: Using a chewing gum without vitamin C (per piece/gum) for 14 days ad libitum
Study NCT02672371 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active eMNS
Description: Each session will consist of right eMNS stimulation that will last 20-minutes. The frequency of stimulation will be random assigned using random frequency interval. The electrodes that will be used will be standard transcutaneous electrodes. The electrodes will be placed on the wrist.
Study NCT02672371 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham eMNS
Description: Each session of sham eMNS will be the same as active, except the device will be turned off. Similar parameters will be used (for 20 minutes and same electrode placement), except no stimulation will be delivered.
Study NCT02869971 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Embosphere® (Prostatic Arteries Embolization)
Description: Prostatic Arteries Embolization with 300-500 µm trisacryl microspheres
Study NCT02869971 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Drug therapy
Description: Combodart (dutasteride 0.5 mg/tamsulosin 0.4 mg)
Study NCT03603925 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Positron Emission Test / Magnetic Resonance (PET/MR)
Description: The Philips Ingenuity PET/MR is used for research scanning. Patients receiving a clinically indicated PET/CT, will be approached to be included in this study. There is no special preparation other than that needed for the prerequisite PET/CT scanning. At the completion of the PET/CT scanning, the subject will be taken to the PET/MR scanner, which is in close in proximity, for research scanning. The research scanning would take up to one hour or as tolerated.
Study NCT03603925 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Positron Emission Test / Computed Tomography (PET/CT)
Description: Patients will receive PET / CT imaging for the detection of cancer or other clinically indicated anomalies. The completed study visit is expected to take approximately 2 hours and not longer than 3 hours.
Study NCT01338909 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prasugrel
Description: Prasugrel 60mg immediate loading dose (Day 0)followed by 10mg/day starting from Day 1 until Day 5
Study NCT01338909 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Clopidogrel
Description: Clopidogrel 150mg/d starting from Day 1
Study NCT00919932 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Paper and pen homework
Description: Homework will be standardized through the use of Judith Beck's dysfunctional thought record (DTR), which is a primary tool for patients to evaluate and respond in writing to their automatic thoughts (Beck 126). The homework will be done on a preprinted form which is assigned weekly and reviewed with their therapists at weekly sessions for 4 weeks.
Study NCT00919932 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Text message system homework.
Description: Homework will be standardized through the use of Judith Beck's dysfunctional thought record (DTR), which is a primary tool for patients to evaluate and respond in writing to their automatic thoughts (Beck 126). The novel text-messaging system allows homework to be submitted directly through an adolescent's cellular phone, includes text-messaged homework reminder prompts, and collates all homework for therapists to review with patients during therapy sessions. This is assigned and reviewed weekly for 4 weeks.
Study NCT02628821 — intervention group
Intervention type: OTHER
Intervention: Preterm Infants treated with non-invasive ventilation.
Study NCT03570307 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: medical VS surgical evacuation of the uterus
Description: mentioned above
Study NCT03810027 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Bladder diary
Description: 3-day bladder diary
Study NCT02844088 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Meningococcus C conjugate vaccine
Study NCT02844088 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Meningococcus C conjugate vaccine
Study NCT04478188 — intervention group
Intervention type: OTHER
Intervention: Measuring Pressure Volume Loop Pre and Post Device Placement
Description: To measure simultaneous pressure and volume of the heart (pressure volumes loops) before and after ventricular assist device placement for cardiogenic shock (a severe form of heart failure) and before and after device removal.
Study NCT01905176 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: In person education on heart failure topics before discharge
Description: Individualized in-person education on HF topics aiming to promote self-care practices by using educational electronic material and booklet
Study NCT01905176 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telephone support and education post-discharge
Description: Individualized telephone support/education of three months duration, on HF topics, aiming to promote self-care practices while evaluating patients' current status and condition
Study NCT01905176 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pre-discharge in person education and post-discharge telephone education and support
Description: Patients receive both interventions of Arm 1 \& 2: individualized pre-discharge counseling/education along with telephone follow-up support for three months, following the same line as mentioned in Arms 1 \& 2
Study NCT03858998 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Case Management Intervention
Description: A 90-day case management intervention to link hospitalized HIV-infected participants with local HIV clinics.
Study NCT03858998 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control
Description: Current routine HIV care in Tanzania.
Study NCT03858998 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control
Description: Current routine HIV care in Tanzania.
Study NCT02023983 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Early discharge
Description: Early discharge (within 72 hours) of selected patients with low risk of complications after myocardial infarction with ST segment elevation, treated with successful percutaneous coronary intervention
Study NCT02820324 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oliceridine
Study NCT02820324 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT02820324 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Morphine
Study NCT03239340 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Osimertinib
Description: Osimertinib is an oral, potent, selective, irreversible inhibitor of both EGFR-tyrosine kinase inhibitor sensitizing and resistance mutations in non-small cell lung cancer with a significant selectivity margin over wild type EGFR.
Study NCT02023983 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard discharge
Description: Discharge after myocardial infarction with ST segment elevation in a standard way accordingly with present practice and physician´s decision (usually 4th-7th day)
Study NCT04751305 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health Coaching
Description: The weekly health coaching (HC) calls were structured to be participant-centered, built on a coach participant relationship, and include participant-determined goals, a self-discovery process to find solutions, patient accountability, and education. Before each HC call, the participants received a short questionnaire on fatigue, QOL, stress, loneliness, and social support which enabled tailoring the HC call to the individual. Educational topics are discussed in the following order: Goal Setting, Monitoring Behaviour, Barrier Management, Social Support, Stress Management, Adapting the Program, Self-Compassion, Sleep \& Nutrition, Reflection, Health Media, Remote Resources, and Maintaining Motivation. However, the order of the educational topics can be adjusted based on the specific participants' needs each week. At the half-way point of the intervention, the participant provided feedback on the HC calls, ensuring optimization of HC impact.
Study NCT04751305 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Online delivered Exercise Classes
Description: The group based remote exercise program was delivered over the Zoom application (2x/wk for first 2 weeks; 1x/wk for the remaining weeks). Classes were one hour long with a ten minute warm up, 40 minute strength and conditioning focused exercise circuits, and a ten minute stretch. Each class was followed by additional time to provide participants with an opportunity to interact with each other, fostering social support.
Study NCT04751305 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Online delivered Exercise Classes
Description: The group based remote exercise program was delivered over the Zoom application (2x/wk for first 2 weeks; 1x/wk for the remaining weeks). Classes were one hour long with a ten minute warm up, 40 minute strength and conditioning focused exercise circuits, and a ten minute stretch. Each class was followed by additional time to provide participants with an opportunity to interact with each other, fostering social support.
Study NCT02753894 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ASP1585
Description: Oral
Study NCT03434873 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: magnetic stimulation
Description: Twenty trains of 50 stimuli at 5 Hz (train duration: 10 seconds) separated by a 40-second pause were delivered for a total of 1000 pulses, once a day for four consecutive days for two weeks
Study NCT02317159 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Imatinib
Description: 400mg imatinib qd PO
Study NCT01814176 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Intubation with GlideScope Video Laryngoscope or Macintosh Direct Laryngoscope
Study NCT03245021 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Opdivo
Description: All patients will receive:~Nivolumab 240mg IV q2-weekly for four cycles~Patients in complete remission (CR):~Nivolumab 240mg IV q2-weekly for four further cycles (8 in total)~Patients with partial response (PR), stable disease (SD), asymptomatic or minor progressive disease (PD) post 4cycles receive:~Nivolumab 240mg IV plus rituximab 375mg/m2 IV q2-weekly for four cycles~Patients in CR:~Nivolumab 240mg IV q2-weekly for four further cycles (8 in total)~Patients with PR, SD, asymptomatic or minor PD post 4 cycles receive:~Nivolumab 240mg IV plus rituximab 375mg/m2 IV q2-weekly for four cycles
Study NCT01433471 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Trichuris suis ova
Description: 2,500 eggs by mouth every two weeks for 12 weeks
Study NCT01433471 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trichuris suis ova
Description: 2,500 eggs by mouth every two weeks for 12 weeks
Study NCT01567462 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Monopolar electrocautery loop in Transurethral resection of bladder tumors
Description: Standard monopolar electrocautery loop in transurethral resection of bladder tumors (TURBT)
Study NCT04182412 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: ARD
Description: surgical reconstruction with laparoscopic technique
Study NCT03607552 — intervention group
Intervention type: DEVICE
Intervention: Non-contrast DWI
Description: Diffusion-weighted imaging (DWI) is a non-contrast MRI technique that typically can be acquired in under 5 minutes. DWI reflects the microscopic cellular environment and can demonstrate differences between normal and malignant breast tissue without the aid of intravenous gadolinium.
Study NCT03607552 — intervention group
Intervention type: DEVICE
Intervention: Non-contrast MRI
Description: Non-contrast MRI scans will include DWI along with anatomical T1-weighted and T2-weighted sequences.
Study NCT06651138 — intervention group
Intervention type: RADIATION
Intervention: Fluoroscopy
Description: Pulsed or Continuous fluoroscopy during MILD procedure
Study NCT03842475 — intervention group
Intervention type: PROCEDURE
Intervention: Roux-en-Y gastric bypass (RYGB)
Description: Bariatric surgery
Study NCT01567462 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: PK Button Vaporization Electrode in transurethral resection of bladder tumors
Description: PlasmaKinetic (PK) Button Vaporization Electrode in transurethral resection of bladder tumors (TURBT)
Study NCT04395820 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Lung function test
Description: MBW
Study NCT04395820 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Imaging
Description: MP-MRI
Study NCT00479986 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pioglitazone
Study NCT00479986 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: placebo
Study NCT01973439 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Intervention 1: PK assessment while on Twice Daily Abacavir
Description: Week 0